These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21543784)

  • 1. Statistical grand rounds: design and analysis of studies with binary- event composite endpoints: guidelines for anesthesia research.
    Mascha EJ; Sessler DI
    Anesth Analg; 2011 Jun; 112(6):1461-71. PubMed ID: 21543784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of weighted composite compared to traditional composite endpoints for the design of randomized controlled trials.
    Bakal JA; Westerhout CM; Armstrong PW
    Stat Methods Med Res; 2015 Dec; 24(6):980-8. PubMed ID: 22275378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian design and analysis of composite endpoints in clinical trials with multiple dependent binary outcomes.
    Zaslavsky BG
    Pharm Stat; 2013; 12(4):207-12. PubMed ID: 23625660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplicity adjustment for composite binary endpoints.
    Rauch G; Kieser M
    Methods Inf Med; 2012; 51(4):309-17. PubMed ID: 22525969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planning and evaluating clinical trials with composite time-to-first-event endpoints in a competing risk framework.
    Rauch G; Beyersmann J
    Stat Med; 2013 Sep; 32(21):3595-608. PubMed ID: 23553898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Easily applicable multiple testing procedures to improve the interpretation of clinical trials with composite endpoints.
    Schüler S; Mucha A; Doherty P; Kieser M; Rauch G
    Int J Cardiol; 2014 Jul; 175(1):126-32. PubMed ID: 24861257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of a binary composite endpoint with missing data in components.
    Quan H; Zhang D; Zhang J; Devlamynck L
    Stat Med; 2007 Nov; 26(26):4703-18. PubMed ID: 17431851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive clinical trial designs with blinded selection of binary composite endpoints and sample size reassessment.
    Roig MB; Melis GG; Posch M; Koenig F
    Biostatistics; 2023 Dec; 25(1):237-252. PubMed ID: 36150142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
    Rauch G; Kieser M; Ulrich S; Doherty P; Rauch B; Schneider S; Riemer T; Senges J
    Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post hoc analyses: after the facts.
    Srinivas TR; Ho B; Kang J; Kaplan B
    Transplantation; 2015 Jan; 99(1):17-20. PubMed ID: 25525920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pros and cons of composite endpoints in anesthesia trials.
    Myles PS; Devereaux PJ
    Anesthesiology; 2010 Oct; 113(4):776-8. PubMed ID: 20808209
    [No Abstract]   [Full Text] [Related]  

  • 12. Repeated Measures Designs and Analysis of Longitudinal Data: If at First You Do Not Succeed-Try, Try Again.
    Schober P; Vetter TR
    Anesth Analg; 2018 Aug; 127(2):569-575. PubMed ID: 29905618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing multiplicity issues of a composite endpoint and its components in clinical trials.
    Huque MF; Alosh M; Bhore R
    J Biopharm Stat; 2011 Jul; 21(4):610-34. PubMed ID: 21516560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic comparison of recurrent event models for application to composite endpoints.
    Ozga AK; Kieser M; Rauch G
    BMC Med Res Methodol; 2018 Jan; 18(1):2. PubMed ID: 29301487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size determination in clinical trials with multiple co-primary binary endpoints.
    Sozu T; Sugimoto T; Hamasaki T
    Stat Med; 2010 Sep; 29(21):2169-79. PubMed ID: 20687162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
    Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
    Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting power of tests for multiple binary outcomes.
    Mascha EJ; Imrey PB
    Stat Med; 2010 Dec; 29(28):2890-904. PubMed ID: 20862669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous inference of a binary composite endpoint and its components.
    Große Ruse M; Ritz C; Hothorn LA
    J Biopharm Stat; 2017; 27(1):56-69. PubMed ID: 26881805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the most appropriate components for a composite clinical trial outcome.
    Bethel MA; Holman R; Haffner SM; Califf RM; Huntsman-Labed A; Hua TA; McMurray J
    Am Heart J; 2008 Oct; 156(4):633-40. PubMed ID: 18926145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of composite binary endpoints in clinical trials.
    Bofill Roig M; Gómez Melis G
    Biom J; 2018 Mar; 60(2):246-261. PubMed ID: 29023990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.